Delivery Order SPE2DB22D3301-SPE2DB25FY4GA

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price of $11,040.84 and an ultimate completion date of December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a medical product, with a ceiling value of $59,802.10. It is a firm fixed-price delivery order contract with a final completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $59,802.10 firm-fixed-price contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO, a specialty medication. The contract has a ceiling value of $27,602.10 and is a firm fixed price agreement with an ultimate completion date of September 13, 2024. The contract is not designated as a set-aside award. As a significant supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $156,970.14 and is for the delivery of Darzalex Faspro, a specialty medication, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of pharmaceutical products. The contract, valued at $22,081.68, is for the delivery of DARZALEX FASPRO, a specialty medication, and has a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and federal healthcare programs. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $138,010.50 firm fixed-price contract is for the delivery of 4,564,309,518 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a completion date of May 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $59,802.10 and a period of performance through May 9, 2025. The contract is not set aside and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $176,653.44, is for the supply of the specialty pharmaceutical DARZALEX FASPRO. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY4GA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $23,920.84 and a period of performance through May 23, 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract is not set aside and is awarded on an open competition basis. As a major supplier of medical and pharmaceutical products to federal agencies, Amerisourcebergen Drug Corp is well-positioned to fulfill the government's diverse medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 12:47 AM